BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 25896349)

  • 1. Regulation of autotaxin expression and secretion by lysophosphatidate and sphingosine 1-phosphate.
    Benesch MG; Zhao YY; Curtis JM; McMullen TP; Brindley DN
    J Lipid Res; 2015 Jun; 56(6):1134-44. PubMed ID: 25896349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone decreases the autotaxin-lysophosphatidate-inflammatory axis in adipose tissue: implications for the metabolic syndrome and breast cancer.
    Meng G; Tang X; Yang Z; Zhao Y; Curtis JM; McMullen TPW; Brindley DN
    FASEB J; 2019 Feb; 33(2):1899-1910. PubMed ID: 30192654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance.
    Samadi N; Bekele R; Capatos D; Venkatraman G; Sariahmetoglu M; Brindley DN
    Biochimie; 2011 Jan; 93(1):61-70. PubMed ID: 20709140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signalling by lysophosphatidate and its health implications.
    Hemmings DG; Brindley DN
    Essays Biochem; 2020 Sep; 64(3):547-563. PubMed ID: 32451553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer.
    Brindley DN; Tang X; Meng G; Benesch MGK
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the autotaxin-lysophosphatidate axis in the development of resistance to cancer therapy.
    Tang X; Benesch MGK; Brindley DN
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Aug; 1865(8):158716. PubMed ID: 32305571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-induced inflammation in mammary adipose tissue stimulates a vicious cycle of autotaxin expression and breast cancer progression.
    Benesch MG; Tang X; Dewald J; Dong WF; Mackey JR; Hemmings DG; McMullen TP; Brindley DN
    FASEB J; 2015 Sep; 29(9):3990-4000. PubMed ID: 26071407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of the Lysophosphatidylcholine/Autotaxin/Lysophosphatidic Acid Axis in Acute-on-Chronic Liver Failure Is Associated With Mortality and Systemic Inflammation by Lysophosphatidic Acid-Dependent Monocyte Activation.
    Trovato FM; Zia R; Napoli S; Wolfer K; Huang X; Morgan PE; Husbyn H; Elgosbi M; Lucangeli M; Miquel R; Wilson I; Heaton ND; Heneghan MA; Auzinger G; Antoniades CG; Wendon JA; Patel VC; Coen M; Triantafyllou E; McPhail MJ
    Hepatology; 2021 Aug; 74(2):907-925. PubMed ID: 33908067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic analysis of autotaxin reveals substrate-specific catalytic pathways and a mechanism for lysophosphatidic acid distribution.
    Saunders LP; Cao W; Chang WC; Albright RA; Braddock DT; De La Cruz EM
    J Biol Chem; 2011 Aug; 286(34):30130-41. PubMed ID: 21719699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysophosphatidic acid and sphingosine 1-phosphate metabolic pathways and their receptors are differentially regulated during decidualization of human endometrial stromal cells.
    BrĂ¼nnert D; Sztachelska M; Bornkessel F; Treder N; Wolczynski S; Goyal P; Zygmunt M
    Mol Hum Reprod; 2014 Oct; 20(10):1016-25. PubMed ID: 24994816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate.
    van Meeteren LA; Ruurs P; Christodoulou E; Goding JW; Takakusa H; Kikuchi K; Perrakis A; Nagano T; Moolenaar WH
    J Biol Chem; 2005 Jun; 280(22):21155-61. PubMed ID: 15769751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autotaxin and chronic inflammatory diseases.
    Magkrioti C; Galaris A; Kanellopoulou P; Stylianaki EA; Kaffe E; Aidinis V
    J Autoimmun; 2019 Nov; 104():102327. PubMed ID: 31471142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible involvement of sphingomyelin in the regulation of the plasma sphingosine 1-phosphate level in human subjects.
    Ohkawa R; Kurano M; Mishima Y; Nojiri T; Tokuhara Y; Kishimoto T; Nakamura K; Okubo S; Hosogaya S; Ozaki Y; Yokota H; Igarashi K; Ikeda H; Tozuka M; Yatomi Y
    Clin Biochem; 2015 Jul; 48(10-11):690-7. PubMed ID: 25863111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of autotaxin, a lysophosphatidic acid-producing enzyme, enhances cardia bifida induced by hypo-sphingosine-1-phosphate signaling in zebrafish embryo.
    Nakanaga K; Hama K; Kano K; Sato T; Yukiura H; Inoue A; Saigusa D; Tokuyama H; Tomioka Y; Nishina H; Kawahara A; Aoki J
    J Biochem; 2014 Apr; 155(4):235-41. PubMed ID: 24451492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate.
    Clair T; Aoki J; Koh E; Bandle RW; Nam SW; Ptaszynska MM; Mills GB; Schiffmann E; Liotta LA; Stracke ML
    Cancer Res; 2003 Sep; 63(17):5446-53. PubMed ID: 14500380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Expression Regulation and Biological Function of Autotaxin.
    Zhang X; Li M; Yin N; Zhang J
    Cells; 2021 Apr; 10(4):. PubMed ID: 33921676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis.
    Black KE; Berdyshev E; Bain G; Castelino FV; Shea BS; Probst CK; Fontaine BA; Bronova I; Goulet L; Lagares D; Ahluwalia N; Knipe RS; Natarajan V; Tager AM
    FASEB J; 2016 Jun; 30(6):2435-50. PubMed ID: 27006447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications for breast cancer treatment from increased autotaxin production in adipose tissue after radiotherapy.
    Meng G; Tang X; Yang Z; Benesch MGK; Marshall A; Murray D; Hemmings DG; Wuest F; McMullen TPW; Brindley DN
    FASEB J; 2017 Sep; 31(9):4064-4077. PubMed ID: 28539367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical introduction of lysophosphatidic acid and autotaxin assays].
    Yatomi Y
    Rinsho Byori; 2010 Jun; 58(6):631-5. PubMed ID: 20662276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autotaxin inhibition reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction.
    Tripathi H; Al-Darraji A; Abo-Aly M; Peng H; Shokri E; Chelvarajan L; R Donahue R; Levitan BM; Gao E; Hernandez G; Morris AJ; Smyth SS; Abdel-Latif A
    J Mol Cell Cardiol; 2020 Dec; 149():95-114. PubMed ID: 33017574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.